Reichert Brings Cutting-Edge Eye Care Tech to Vision Expo East 2025


 
As eye care rapidly evolves, Vision Expo East 2025 is the place to see where innovation meets clinical excellence — and Reichert is leading the charge. At booth F2201, practitioners can experience hands-on demos of Reichert’s latest breakthroughs in tonometry, digital refraction, and dry eye diagnostics. Of particular note is the new Tono-Vera® Tonometer, which simplifies intraocular pressure readings with its patented ActiView™ Positioning System. Reichert is also showcasing its premium Phoroptor® VRx Digital Refraction System alongside the intuitive SightChek® Digital Phoroptor, offering powerful options for practices of all sizes. With dry eye disease on the rise, their suite of evaluation and therapy devices helps practices meet growing demand. Visitors can also explore the Ocular Response Analyzer® G3, a game-changer in glaucoma management with its unique Corneal Hysteresis and IOPcc metrics. Plus, for those who stop by for a demo, there’s a chance to win a $1,000 Visa gift card — a rewarding way to explore the future of vision care.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…